Search results
Results: 89
Number of items: 89
-
Verstegen, N. J. M., Jorritsma, T., ten Brinke, A., Barberis, M., & van Ham, S. M. (2024). TCR-CD3 signal strength regulates plastic coexpression of IL-4 and IFN-γ in Tfh-like cells. Frontiers in Immunology, 15, Article 1481243. https://doi.org/10.3389/fimmu.2024.1481243 -
van Dam, K. P. J., Wieske, L., Stalman, E. W., Kummer, L. Y. L., van der Kooi, A. J., Raaphorst, J., van de Beek, D., Verschuuren, J. J. G. M., Ruiter, A. M., Brusse, E., van Doorn, P. A., Baars, A. E., van der Pol, W. L., Goedee, H. S., ten Brinke, A., van Ham, S. M., Rispens, T., Kuijpers, T. W., Eftimov, F., & the T2B! Immunity Against SARS-CoV-2 Study Group (2024). Patient-reported daily functioning after SARS-CoV-2 vaccinations in autoimmune neuromuscular diseases. European Journal of Neurology, 31(12), Article e16409. https://doi.org/10.1111/ene.16409 -
Verkerk, T., Pappot, A. T., Jorritsma, T., King, L. A., Duurland, M. C., Spaapen, R. M., & van Ham, S. M. (2024). Isolation and expansion of pure and functional γδ T cells. Frontiers in Immunology, 15, Article 1336870. https://doi.org/10.3389/fimmu.2024.1336870 -
van Dam, K. P. J., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Busch, M. H., Verstegen, N. J. M., van Ham, S. M., Tas, S. W., & T2B! immunity against SARS-CoV-2 study group (2023). Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations. Journal of autoimmunity, 135, Article 102984. https://doi.org/10.1016/j.jaut.2022.102984
-
Koers, J., Sciarrillo, R., Derksen, N. I. L., Vletter, E. M., Fillié-Grijpma, Y. E., Raveling-Eelsing, E., Graça, N. A. G., Leijser, T., Pas, H. H., van Nijen-Vos, L. L., Braham, M. V. J., Buisman, A.-M., de Jong, J., Schriek, A. I., Tio-Gillen, A. P., Teng, Y. K. O., Steenhuis, M., Swaneveld, F. H., de Taeye, S. W., ... T2B Consortium (2023). Differences in IgG autoantibody Fab glycosylation across autoimmune diseases. Journal of Allergy and Clinical Immunology, 151(6), 1646-1654. https://doi.org/10.1016/j.jaci.2022.10.035
-
van Kempen, Z. L. E., Hogenboom, L., Toorop, A. A., Steenhuis, M., Stalman, E. W., Kummer, L. Y. L., van Dam, K. P. J., Bloem, K., ten Brinke, A., van Ham, S. M., Kuijpers, T. W., Wolbink, G. J., Loeff, F. C., Wieske, L., Eftimov, F., Rispens, T., Strijbis, E. M. M., Killestein, J., & T2B! immunity against SARS-CoV-2 study group (2023). Ocrelizumab Concentration Is a Good Predictor of SARS-CoV-2 Vaccination Response in Patients with Multiple Sclerosis. Annals of Neurology, 93(1), 103-108. https://doi.org/10.1002/ana.26534 -
van Dam, K. P. J., Tas, S. W., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Busch, M. H., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2023). Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity. BMC Infectious Diseases, 23, Article 332. https://doi.org/10.1186/s12879-023-08298-6
Page 3 of 9